NASDAQ:KZR   Kezar Life Sciences, Inc.
after a lateral phase of a couple of months, try a breakout to resume a bullish direction with a target of around 1.20, otherwise if it fails it could quickly return to 092 and then 080

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.